Artificial pancreas nears reality: tech breakthrough for diabetes patients
International team develops implantable artificial pancreas
Researchers from the Technion-Israel Institute of Technology, MIT, and other US universities have made a crucial step towards a major goal in modern medicine: creating an implantable artificial pancreas that can function autonomously within the human body. This breakthrough device, led by Shady Farah, professor of Chemical Engineering at the Technion, could render daily insulin injections and external pumps obsolete for diabetes patients.
How the artificial pancreas works
The implant acts as a living drug: a biological system capable of growing, detecting chemical changes in the body, and responding automatically, mimicking the behavior of a healthy pancreas. The device is compact, containing live insulin-producing cells encapsulated within a protective crystalline structure.
Key Features:- Allows oxygen and nutrient passage while shielding cells from the immune system
- Measures blood glucose levels in real-time and releases exact insulin amounts needed
- Overcomes historical immunological rejection issues with prior attempts
Promising results in animal trials
Studies in diabetic rats demonstrated stable glucose control over extended periods. Tests in primates also confirmed cell viability and insulin production capabilities. While currently focused on diabetes, the technology's adaptability could extend to treating other conditions like hemophilia or metabolic disorders.
Next steps and potential impact
Further development and clinical trials are necessary before this artificial pancreas becomes a reality for humans. If successful, it could revolutionize diabetes management, improving quality of life for millions worldwide and potentially paving the way for innovative treatments across multiple disease areas.